SUMITOMO PHARMA CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 410 JPY | +2.50% |
|
+5.40% | -12.02% |
| Apr. 22 | Lull in Geopolitical Tensions Lifts Asian Stock Markets | MT |
| Apr. 17 | Jefferies Adjusts Sumitomo Pharma’s Price Target to 420 Yen From 520 Yen, Keeps at Hold | MT |
ETFs positioned on Sumitomo Pharma Co., Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.38% | 15 M€ | +7.34% | ||
| 0.15% | 67,864 M€ | +14.28% | ||
| 0.13% | 31,732 M€ | +14.31% | - | |
| 0.13% | 1,198 M€ | +13.48% | - | |
| 0.11% | 1,120 M€ | +0.40% | ||
| 0.10% | 16,729 M€ | +13.38% | - | |
| 0.06% | 4 M€ | +13.95% | ||
| 0.06% | 60 M€ | +14.42% | ||
| 0.05% | 14 M€ | +15.63% | ||
| 0.05% | 73 M€ | +11.61% | ||
| 0.03% | 5,115 M€ | +13.58% | ||
| 0.03% | 10,207 M€ | +14.32% | ||
| 0.03% | 18 M€ | +16.15% | - | |
| 0.02% | 144,586 M€ | +14.49% | ||
| 0.02% | 20,721 M€ | +13.52% | - | |
| 0.02% | 66,066 M€ | +14.68% | - | |
| 0.01% | 773 M€ | -.--% | - | |
| 0.01% | 7 M€ | +1.95% | - | |
| 0.00% | 31 M€ | +3.50% | - | |
| 0.00% | 10 M€ | -3.35% | - | |
| 0.00% | 34 M€ | +4.85% | - | |
| 0.00% | 389 M€ | +6.83% | - | |
| 0.00% | 39 M€ | +3.67% | - | |
| 0.00% | 302 M€ | +3.80% | - | |
| 0.00% | 34 M€ | +2.14% | - |
Sumitomo Pharma Co., Ltd. (formerly Sumitomo Dainippon Pharma Co., Ltd.) specializes in development, manufacturing and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceuticals (92.9%): for cardiovascular, gastrointestinal and infectious diseases, central nervous systems disorders and allergies treatment;
- other (7.1%): veterinary drugs, food additives, industrial chemical products, etc.
Net sales are distributed geographically as follows: Japan (39.8%), the United States (50.4%), North America (0.9%) and other (8.9%).
Sector
Pharmaceuticals
Calendar
2024-05-13
- Q4 2023 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
8
Last Close Price
410
JPY
Average target price
333.8
JPY
Spread / Average Target
-18.60%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -12.02% | 1.03B | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- 4506 Stock
- Funds and ETFs Sumitomo Pharma Co., Ltd.
